Abstract
SummaryK. 1 Human monocytes but not monocyte-derived dendritic cells express Toll-like receptor 9 mRNA and can be activated by CpG-ODNK. 2 The heat shock protein Gp96 triggers classical signaling cascades via Toll-like receptor 2 and 4K. 3 TNF mediates accelerated growth of Mycobacterium tuberculosis in human dendritic cellsK. 4 HSP60 of Chlamydia pneumoniae stimulates professional antigen presenting cells dependent on TLR2 and TLR4K. 5 Toll-like receptor-dependent microbial stimuli modulate cytokine responses in antigen presenting cellsK. 6 Human milk-derived lactoferrin suppresses the development of adjuvant arthritis in ratsK. 7 N-glycosylation of FcγRIII: A mechanism of regulating receptor affinityK. 8 Ionic currents of human macrophages after microinjection of lipopolysaccharideK. 9 Differentiation of monocyte-derived dendritic cells affects the growth of Toxoplasma gondiiK. 10 The macrophage receptor for heat shock protein 60 is saturable, specific, and different from receptors for other stress proteinsK. 11 Murine Toll-like receptors 7, 8 and 9: Sequence relationship and expression patterns in different cell linesK. 12 Activity of synthetic peptidoglycan structuresK. 13 Characterization of a mutant rat strain lacking expression of the NK receptor NKR-P1AK. 14 Diverse effects of interferon-γ and tumor necrosis factor-α on polymorphonuclear neutrophils: Escape from apoptosis, induction of cytokine synthesis and differentiation to antigen presenting cellsK. 15 Membranal factor H related proteins on B cells and neutrophilsK. 16 Localization of functional domains in the porcine analogue of complement factor HK. 17 Characterization of a mutant serum factor H in a patient with atypical hemolytic uremic syndromeK. 18 Candida albicans yeast forms bind complement regulatory factors H and FHL-1K. 19 «Ignorance» of antigen-specific, murine CD4+ and CD8+ T cells is overruled by lipopolysaccharide and leads to specific induction of IFN-γK. 20 Impaired glucose tolerance is associated with increased serum levels of interleukin-6 and acute phase proteins indicating systemic inflammationK. 21 Decreased superoxide radical production in alveolar macrophages of NO2-exposed ratsK. 22 Liver specificity of transcription of the gene encoding MASP-2 and MAp19 is determined by a 193bp sequence upstream of the transcription start siteK. 23 The gram-negative bacterium Chlamydia trachomatis L2 stimulates innate immune cells independently of lipopolysaccharideK. 24 The antibiotic bactericidal/permeability-increasing protein is expressed in human dermal fibroblastsK. 25 Antigen transport from skin to lymph node revisitedK. 26 De novo expression of anaphylatoxin C5a receptors in hepatocytes after in vivo treatment of rats with lipopolysaccharide: Consequences for the regulation of C5a-induced glucose release and acute phase protein synthesisK. 27 Constitutive expression and regulation of rat complement factor H in primary cultures of hepatocytes and Kupffer cellsK. 28 The role of Toll-like receptors in the control of adaptive immune responsesK. 29 Human neutrophils store IL-8 inside the cell to release it upon activationK. 30 Soluble CD14 replaces the lack of membrane bound CD14 but not of lipopolysaccharide binding protein in vivoK. 31 CpG-rich oligonucleotides exert anti-viral effects on hepatocellular hepatitis B virus replication via cytokine release from non-parenchymal liver cellsK. 32 Cytoplasmic lipopolysaccharide does not activate cytokine gene transcriptionK. 33 TNF-α, IL-1β, and MIP-2 release in IgG immune complex alveolitis is strongly dependent on both FcγRIII and C5aRK. 34 Alveolar macrophages mediate immune complex lung injury via FcγRIII triggeringK. 35 Interactions of human NKG2D with its ligandsK. 36 Activation of CD34+ peripheral blood stem cells by lipopolysaccharide is mediated via TNF-α released by monocytesK. 37 Cross-linking of anti-CD3 antibodies by FcγRII/III-receptors on liver endothelial cells leads to preferential NK-T cell depletion in the liverK. 38 Activation of human coronary endothelial cells but not human umbilical vein endothelial cells by bacterial peptidoglycan and lipopeptide
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.